Endoscopic Mucosal Resection

Endoscopic Mucosal Resection

 

Used for resection of superficial neoplasms

Basic principles are demarcation of the lesion, submucosal injection to lift the lesion and endoscopic snare resection.

 

Paris classification: 

developed by the Japanese Society of Gastrointestinal Endoscopists JSGE in 2002 –

(All are) Superficial = 0

Type 0-I = polypoid

Type 0-II = non-polypoid

0-Ip = polypoid, pedunculated

0-Is = polypoid, sessile

0-IIa = sessile, slightly elevated

0-IIb = sessile, flat

0-IIc = sessile, slightly depreseed

0-III = excavated

 

Vienna Classification

 

Non-invasive (low-grade, high-grade)

Invasive (intramucosal cancer, cancer infiltrating submucosa)

 

EUS produces an image with 9 distinct layers to the mucosal wall. The depth of invasion determines the likelihood of LN involvement.

Accuracy of EUS:         77% for TI disesase

                                    90% for T4 disease

                                    75% for LN involvement

Schematic of penetration as determined by histology

 

False-positive EUS images can be due to peritumour inflammation

False-negative due to to micrometastases (upto 44%)

 

Indications

1.     Definitive treatment of superficial pre-malignant and well-to-moderately differentiated malignancies when there are no LN or distant metastases.

2.     As part of the staging for early GI cancer

SCC of oesophagus: JSGE guidelines advice lesions less than 2cm long and covering less than 1/3rd circumference

Barrett’s: For irregularities including nodularity or ulceration. IF the specimen confirms definitive resection of cancer or only high-grade dysplasia, then ablative therapy should be given. If however, It shows cancer invading the margin (particularly deep margin), either surgery or systemic therapy should be considered.

Early gastric cancer:

NB. JSGE states that well to moderately differentiated tubular and papillary adenocarcinomas are differentiated carcinomas whereas signet ring cell and poorly differentiated are undifferentiated.

Decision to EMR depends on the size of the lesion, the depth of invasion, presence of ulceration and whether its differentiated or undifferentiated.

Absolute indications: lesions that are intramucosal and less than 2cm, whilst macroscopic type doesn’t matter there shouldn’t be any ulceration (UL-)

 

Extended indications:

       UL- T1a differentiated cancers >2cm

       UL+ T1a differentiated cancers <3cm

       UL- T1a undifferentiated cancers <2cm

HOWEVER, for these extended indications, the JSGE recommends ESD (endoscopic submucosal dissection), because a retrospective Japanese study showed that R0 margins are achieved more with ESD in these cases. There are no randomised studies.

In the UK, standard treatment for extended indications would be surgery.

 

Duodenal lesions:

EMR can be used to resect or stage ampullary/periampullary adenomas, early carcinomas, ampullary submucosal lesions.

Additional indications can be neuroendocrine tumours.

However, they are associated with substantial rates of complications.

 

Colonic lesions

(not detailed)

 

Mark Henwood’s oesophagus EMR 07/01/2019

Define the distal extent of the lesion, inject mix (gelofusin, adrenaline 1:1000, indigo blue) into the edges to lift, place snare around it and cut

The edges looked to be nodular still afterwards and some of the lesion seemed to be left behind but these couldn’t be lifted to get a snare on, so were left behind.

 

Mark Henwood’s gastric EMR 07/01/2019

Ulcerated lesion on lesser curve.

Using cap assisted (rubber band ligation) he took it in pieces – placing rubber bands to lift, cutting with snare and then retrieving using the suction, one piece at a time until all of it was removed. Again, edges looked nodular.